We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

6 hedge funds and large institutions have $39.4M invested in Altamira Therapeutics Ltd in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+6
Holders Change %
–
% of All Funds
0.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.4M
2
TAM
Tiverton Asset Management
Delaware
+$10.4M
3
RCM
RA Capital Management
Massachusetts
+$5.94M
4
CCP
Clough Capital Partners
Massachusetts
+$2.97M
5
SFM
Sphera Funds Management
Israel
+$991K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ABI
1
Adamant Biomedical Investments
Switzerland
$10M +$13.4M +27 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$9.68M +$10.4M +21 New
TAM
3
Tiverton Asset Management
Delaware
$9.62M +$10.4M +21 New
RCM
4
RA Capital Management
Massachusetts
$5.42M +$5.94M +12 New
CCP
5
Clough Capital Partners
Massachusetts
$2.97M +$2.97M +6 New
SFM
6
Sphera Funds Management
Israel
$1.11M +$991K +2 New
SIM
7
Spark Investment Management
New York
$109K – – –
Goldman Sachs
8
Goldman Sachs
New York
$104K – – –
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$88K – – –
Credit Agricole
10
Credit Agricole
France
$82K – – –
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$69K – – –
CSS
12
Cubist Systematic Strategies
Connecticut
$60K – – –
Morgan Stanley
13
Morgan Stanley
New York
$50K – – –
Deutsche Bank
14
Deutsche Bank
Germany
$15K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$14K – – –
U
16
UBS
Switzerland
$10K – – –
GSC
17
Ground Swell Capital
South Carolina
$3K – – –

CYTO Hedge Fund Activity: Q3 2014 in Review

6 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q3 2014, worth a combined $39.4M.

Buyers outnumbered sellers: 6 funds opened new CYTO positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $10.4M.

  • 6 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $39.4M of Altamira Therapeutics Ltd stock for Q3 2014.
  • 6 funds opened new Altamira Therapeutics Ltd positions in Q3 2014 and 0 closed out, a net change of +6 holders.
  • The largest Altamira Therapeutics Ltd buyer in Q3 2014 was Fidelity Investments, an estimated $10.4M added.

Based on aggregated 13F filings for Q3 2014.